TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours

被引：93

作者：

Griewank, K. G. ^{[1
]}

Murali, R. ^{[2
,3
]}

Schilling, B. ^{[1
]}

Scholz, S. ^{[4
]}

Sucker, A. ^{[1
]}

Song, M. ^{[1
]}

Suesskind, D. ^{[5
]}

Grabellus, F. ^{[6
]}

Zimmer, L. ^{[1
]}

Hillen, U. ^{[1
]}

Steuhl, K-P ^{[4
]}

Schadendorf, D. ^{[1
]}

Westekemper, H. ^{[4
]}

Zeschnigk, M. ^{[7
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, D-45147 Essen, Germany

[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA

[3] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA

[4] Univ Duisburg Essen, Univ Hosp, Dept Ophthalmol, D-45147 Essen, Germany

[5] Univ Tubingen Hosp, Dept Ophthalmol, D-72076 Tubingen, Germany

[6] Univ Duisburg Essen, Univ Hosp, Inst Pathol & Neuropathol, D-45147 Essen, Germany

[7] Univ Duisburg Essen, Univ Hosp, Inst Human Genet, D-45147 Essen, Germany

来源：

BRITISH JOURNAL OF CANCER | 2013年 / 109卷 / 02期

关键词：

melanoma; dermatology; telomerase; ophthalmology; cancer genetics; MELANOCYTIC LESIONS; SOMATIC MUTATIONS; BRAF MUTATIONS; HUMAN CANCER; GENE; CLASSIFICATION;

D O I：

10.1038/bjc.2013.312

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Recently, activating mutations in the TERT promoter were identified in cutaneous melanoma. We tested a cohort of ocular melanoma samples for similar mutations. Methods: The TERT promoter region was analysed by Sanger sequencing in 47 uveal (ciliary body or choroidal) melanomas and 38 conjunctival melanomas. Results: Mutations of the TERT promoter were not identified in uveal melanomas, but were detected in 12 (32%) conjunctival melanomas. Mutations had a UV signature and were identical to those found in cutaneous melanoma. Conclusion: Mutations of TERT promoter with UV signatures are frequent in conjunctival melanomas and favour a pathogenetic kinship with cutaneous melanomas. Absence of these mutations in uveal melanomas emphasises their genetic distinction from cutaneous and conjunctival melanomas.

引用

页码：497 / 501

页数：5

共 38 条

[1] RAS MUTATIONS IN HUMAN-MELANOMA - A MARKER OF MALIGNANT PROGRESSION [J].

BALL, NJ ;

YOHN, JJ ;

MORELLI, JG ;

NORRIS, DA ;

GOLITZ, LE ;

HOEFFLER, JP .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (03) :285-290

[2] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].

Chapman, Paul B. ;

Hauschild, Axel ;

Robert, Caroline ;

Haanen, John B. ;

Ascierto, Paolo ;

Larkin, James ;

Dummer, Reinhard ;

Garbe, Claus ;

Testori, Alessandro ;

Maio, Michele ;

Hogg, David ;

Lorigan, Paul ;

Lebbe, Celeste ;

Jouary, Thomas ;

Schadendorf, Dirk ;

Ribas, Antoni ;

O'Day, Steven J. ;

Sosman, Jeffrey A. ;

Kirkwood, John M. ;

Eggermont, Alexander M. M. ;

Dreno, Brigitte ;

Nolop, Keith ;

Li, Jiang ;

Nelson, Betty ;

Hou, Jeannie ;

Lee, Richard J. ;

Flaherty, Keith T. ;

McArthur, Grant A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516

[3] Distinct sets of genetic alterations in melanoma [J].

Curtin, JA ;

Fridlyand, J ;

Kageshita, T ;

Patel, HN ;

Busam, KJ ;

Kutzner, H ;

Cho, KH ;

Aiba, S ;

Bröcker, EB ;

LeBoit, PE ;

Pinkel, D ;

Bastian, BC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2135-2147

[4] Somatic activation of KIT in distinct subtypes of melanoma [J].

Curtin, John A. ;

Busam, Klaus ;

Pinkel, Daniel ;

Bastian, Boris C. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4340-4346

[5] Mutations of the BRAF gene in human cancer [J].

Davies, H ;

Bignell, GR ;

Cox, C ;

Stephens, P ;

Edkins, S ;

Clegg, S ;

Teague, J ;

Woffendin, H ;

Garnett, MJ ;

Bottomley, W ;

Davis, N ;

Dicks, N ;

Ewing, R ;

Floyd, Y ;

Gray, K ;

Hall, S ;

Hawes, R ;

Hughes, J ;

Kosmidou, V ;

Menzies, A ;

Mould, C ;

Parker, A ;

Stevens, C ;

Watt, S ;

Hooper, S ;

Wilson, R ;

Jayatilake, H ;

Gusterson, BA ;

Cooper, C ;

Shipley, J ;

Hargrave, D ;

Pritchard-Jones, K ;

Maitland, N ;

Chenevix-Trench, G ;

Riggins, GJ ;

Bigner, DD ;

Palmieri, G ;

Cossu, A ;

Flanagan, A ;

Nicholson, A ;

Ho, JWC ;

Leung, SY ;

Yuen, ST ;

Weber, BL ;

Siegler, HF ;

Darrow, TL ;

Paterson, H ;

Marais, R ;

Marshall, CJ ;

Wooster, R .

NATURE, 2002, 417 (6892) :949-954

[6] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].

Flaherty, Keith T. ;

Robert, Caroline ;

Hersey, Peter ;

Nathan, Paul ;

Garbe, Claus ;

Milhem, Mohammed ;

Demidov, Lev V. ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

Mohr, Peter ;

Dummer, Reinhard ;

Trefzer, Uwe ;

Larkin, James M. G. ;

Utikal, Jochen ;

Dreno, Brigitte ;

Nyakas, Marta ;

Middleton, Mark R. ;

Becker, Juergen C. ;

Casey, Michelle ;

Sherman, Laurie J. ;

Wu, Frank S. ;

Ouellet, Daniele ;

Martin, Anne-Marie ;

Patel, Kiran ;

Schadendorf, Dirk .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114

[7] From genes to drugs: targeted strategies for melanoma [J].

Flaherty, Keith T. ;

Hodi, F. Stephen ;

Fisher, David E. .

NATURE REVIEWS CANCER, 2012, 12 (05) :349-361

[8] BRAF mutations in conjunctival melanoma [J].

Gear, J ;

Willimas, H ;

Kemp, EG ;

Roberts, F .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (08) :2484-2488

[9] T1799A BRAF mutations in conjunctival melanocytic lesions [J].

Goldenberg-Cohen, N ;

Cohen, Y ;

Rosenbaum, E ;

Herscovici, Z ;

Chowers, I ;

Weinberger, D ;

Pe'er, J ;

Sidransky, D .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (09) :3027-3030

[10] Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas [J].

Griewank, Klaus G. ;

Westekemper, Henrike ;

Murali, Rajmohan ;

Mach, Monika ;

Schilling, Bastian ;

Wiesner, Thomas ;

Schimming, Tobias ;

Livingstone, Elisabeth ;

Sucker, Antje ;

Grabellus, Florian ;

Metz, Claudia ;

Suesskind, Daniela ;

Hillen, Uwe ;

Speicher, Michael R. ;

Woodman, Scott E. ;

Steuhl, Klaus-Peter ;

Schadendorf, Dirk .

CLINICAL CANCER RESEARCH, 2013, 19 (12) :3143-3152

← 1 2 3 4 →